Aardvark Therapeutics, Inc. - Common Stock (NQ:AARD)

1.390 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aardvark Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); and New Era Energy & Digital, Inc. (NASDAQ: NUAI): Grabar Law Office is Investigating Claims on Your Behalf

September 10, 2026

From Grabar Law Office

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD

September 08, 2026

From Pomerantz LLP

Via GlobeNewswire

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

September 08, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

AARDVARK THERAPEUTICS, INC. (AARD) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aardvark Therapeutics, Inc. Investors of Upcoming Deadline

September 08, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

AARD Stockholders Have Rights – If You Lost Money Investing in Aardvark Therapeutics, Inc. Contact Robbins LLP for Information About Recovering Your Losses

September 04, 2026

From Robbins LLP

Via Business Wire

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

September 04, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aardvark Therapeutics, Inc. (AARD)

September 02, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD

September 01, 2026

From Pomerantz LLP

Via GlobeNewswire

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

September 01, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); Hub Group, Inc. (NASDAQ: HUBG); and Insulet Corporation (NASDAQ: PODD): Grabar Law Office is Investigating Claims on Your Behalf

September 01, 2026

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and The Simply Good Foods Company (NASDAQ: SMPL); Grabar Law Office is Investigating Claims on Your

August 31, 2026

From Grabar Law Office

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 28, 2026

Gainers Aardvark Therapeutics (NASDAQ:AARD) shares increased by 8.5% to $6.28 during Friday's after-market session. The market value of their outstanding shares is at $144.8 million. TransCode...

Via Benzinga

Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Aardvark Therapeutics, Inc. and Encourages Investors to Contact the Firm

August 27, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and Hub Group, Inc. (NASDAQ: HUBG); Grabar Law Office is Investigating Claims on Your Behalf

August 27, 2026

From Grabar Law Office

Via GlobeNewswire

Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

August 26, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Deadline Approaching: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

August 26, 2026

From Law Offices of Howard G. Smith

Via Business Wire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Aardvark Therapeutics, Inc. (AARD)

August 26, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD

August 25, 2026

From Pomerantz LLP

Via GlobeNewswire

Deadline Soon: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

August 25, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

August 25, 2026

From Schall, Brown & Schwartz LLP

Via GlobeNewswire

Oct. 31st DEADLINE ALERT: Investors Who Lost Money With Aardvark Therapeutics, Inc. (NASDAQ: AARD) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit

August 25, 2026

From The Shareholders Foundation, Inc.

Via Business Wire

Did You Lose Money Investing in Aardvark Therapeutics, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against AARD

August 24, 2026

San Diego, California--(Newsfile Corp. - August 24, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class...

Via Newsfile

Topics Initial Public Offering Lawsuit

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Aardvark Therapeutics, Inc. (AARD) Encourages Shareholders To Inquire About Securities Fraud Class Action

August 24, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Law Offices of Howard G. Smith Encourages Aardvark Therapeutics, Inc. (AARD) Shareholders To Inquire About Securities Fraud Class Action

August 24, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD

August 21, 2026

From Pomerantz LLP

Via GlobeNewswire

Law Offices of Frank R. Cruz Encourages Aardvark Therapeutics, Inc. (AARD) Shareholders to Inquire About Securities Fraud Class Action

August 21, 2026

From Law Offices of Frank R. Cruz

Via Business Wire

Aardvark Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AARD

August 21, 2026

From The DJS Law Group

Via Business Wire

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

August 20, 2026

From Schall, Brown & Schwartz LLP

Via Business Wire

Levi & Korsinsky Reminds Aardvark Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 13, 2026 - AARD

August 20, 2026

From Levi & Korsinsky, LLP

Via Business Wire

AARDVARK THERAPEUTICS, INC. (AARD) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aardvark Therapeutics, Inc. Investors of Upcoming Deadline

August 20, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.